| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |